News release 2013 Covis Pharma to Acquire US Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate® April 4, 2013 News release Contact Us 2023 2022 2021 2020 2018 2017 2015 2013
Covis Pharma to Acquire US Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate® April 4, 2013